FDA designation provides potentially seven years of market exclusivity after approval and expanded partnering opportunities for tecarfarin PONTE VEDRA, Fla., April 9, 2024 /PRNewswire/ -- Cadrenal ...
Research and Markets has announced the addition of the "Ventricular Assistance Devices Global Market - Forecast to 2023" report to their offering. The heart conditions are considered advanced or end ...
Ventricular assist devices can be used as bridge to heart recovery without need for heart transplant
NEW ORLEANS, Nov. 9 - A heart ventricular assist device (VAD) is used as a bridge to organ transplantation, maintaining a patient's cardiac function until a donor organ becomes available. In some ...
Within the last 24 months, I have financial relationship(s) or affiliation(s) with a manufacturer, marketer, reseller, or distributor of a healthcare product or service involved in the management of ...
Nayeem Imtiaz and William Stoddard presented project updates at the 67th ASAIO conference in Chicago. William presented “Advancements of DragonHeart BiVentricular Assist Device”, an update on our ...
(MENAFN- PR Newswire) The increase in prevalence of heart failure, technological advancements in the field of medical devices, the surge in patient awareness about ventricular assist devices, and the ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results